Eton Pharmaceuticals (ETON) Total Current Liabilities (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Total Current Liabilities data on file, last reported at $38.5 million in Q4 2025.

• For the quarter ending Q4 2025, Total Current Liabilities rose 92.96% year-over-year to $38.5 million; the trailing twelve-month figure through Dec 2025 stood at $38.5 million (up 92.96% YoY), and the FY2025 full-year result was $38.5 million, up 92.96% from the prior year.
• Total Current Liabilities retreated to $38.5 million in Q4 2025, from $44.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $44.2 million in Q3 2025 to a low of $3.1 million in Q2 2021.
• A 5-year average of $14.9 million and a median of $10.0 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities retreated 13.04% in 2022 and soared 151.52% in 2023, its largest moves.
• Tracing ETON's Total Current Liabilities over 5 years: stood at $4.6 million in 2021, then surged by 41.75% to $6.5 million in 2022, then soared by 151.37% to $16.2 million in 2023, then grew by 22.82% to $19.9 million in 2024, then soared by 92.96% to $38.5 million in 2025.
• Business Quant data shows ETON's Total Current Liabilities at $38.5 million in Q4 2025, $44.2 million in Q3 2025, and $38.6 million in Q2 2025.